Procalcitonin in intensive care units: the PRORATA trial
LANCET (2010)
期刊
LANCET
卷 375, 期 9726, 页码 1605-1605出版社
ELSEVIER SCIENCE INC
关键词
作者
我是这篇论文的作者
推荐
A cytokine panel and procalcitonin in COVID-19, a comparison between intensive care and non-intensive care patients
Tina Mazaheri, Ruvini Ranasinghe, Wiaam Al-Hasani, James Luxton, Jessica Kearney, Allison Manning, Georgios K. Dimitriadis, Tracey Mare, Royce P. Vincent
PLOS ONE (2022)
Telemedicine in Intensive Care Units: Scoping Review
Camille Guinemer, Martin Boeker, Daniel Fuerstenau, Akira-Sebastian Poncette, Bjoern Weiss, Rudolf Moergeli, Felix Balzer
JOURNAL OF MEDICAL INTERNET RESEARCH (2021)
An educational programme in neonatal intensive care units (SEPREVEN): a stepped-wedge, cluster-randomised controlled trial
Laurence Caeymaex, Dominique Astruc, Valerie Biran, Leila Marcus, Florence Flamein, Stephane Le Bouedec, Bernard Guillois, Radia Remichi, Faiza Harbi, Xavier Durrmeyer, Florence Casagrande, Nolwenn Le Sache, Darina Todorova, Ali Bilal, Damien Olivier, Audrey Reynaud, Cecile Jacquin, Jean-Christophe Roze, Richard Layese, Claude Danan, Camille Jung, Fabrice Decobert, Etienne Audureau
LANCET (2022)
Family-clinician shared decision making in intensive care units: Cluster randomized trial in China
Xinchun Liu, Gerald Humphris, Aijing Luo, Mingshi Yang, Jin Yan, Shaohua Huang, Siyu Xiao, Ailian Lv, Guobao Wu, Peigen Gui, Qingyan Wang, Yudong Zhang, Yaxin Yan, Nie Jing, Jie Xu
PATIENT EDUCATION AND COUNSELING (2022)
Determination in Galicia of the required beds at Intensive Care Units
Ivan Area, Xurxo Hervada Vidal, Juan J. Nieto, Maria Jesus Purrinos Hermida
ALEXANDRIA ENGINEERING JOURNAL (2021)
Management of Very Old Patients in Intensive Care Units
Xin Ding, Hui Lian, Xiaoting Wang
AGING AND DISEASE (2021)
Protocol Use in Surgical Intensive Care Units
Christopher P. Michetti, Anna B. Newcomb, Chang Liu
JOURNAL OF SURGICAL RESEARCH (2021)
New challenges in cardiac intensive care units
Enzo Lusebrink, Antonia Kellnar, Clemens Scherer, Kathrin Krieg, Mathias Orban, Tobias Petzold, Sven Peterss, Stefan Kaab, Stefan Brunner, Daniel Braun, Christian Hagl, Jorg Hausleiter, Steffen Massberg, Martin Orban
CLINICAL RESEARCH IN CARDIOLOGY (2021)
Integrative therapies in intensive care units: A scoping review
Welile M. Mamba, Celia J. Filmalter, Tanya Heyns
JOURNAL OF CLINICAL NURSING (2021)
Smart Health-Enhanced Early Mobilisation in Intensive Care Units
Maria Ferre, Edgar Batista, Agusti Solanas, Antoni Martinez-Balleste
SENSORS (2021)
The distinct microbial community patterns and pathogen transmission routes in intensive care units
Junwei Chen, Lei Ji, Guangzhou Xiong, Kang Ning
JOURNAL OF HAZARDOUS MATERIALS (2023)
Capacity of intensive care units in Ghana
Moses Siaw-Frimpong, Sunkaru Touray, Nana Sefa
JOURNAL OF CRITICAL CARE (2021)
How Physicians Discuss Uncertainty With Parents in Intensive Care Units
Sanne Prins, Annemiek J. Linn, Anton H. L. C. van Kaam, Moniek van de Loo, Job B. M. van Woensel, Marc van Heerde, Peter H. Dijk, Martin C. J. Kneyber, Matthijs de Hoog, Sinno H. P. Simons, Aranka A. Akkermans, Ellen M. A. Smets, Marij A. Hillen, Mirjam A. de Vos
PEDIATRICS (2022)
Combatting resistance: Understanding multi-drug resistant pathogens in intensive care units
Jianying Teng, Saber Imani, Aiping Zhou, Yuheng Zhao, Lailing Du, Shuli Deng, Jun Li, Qingjing Wang
BIOMEDICINE & PHARMACOTHERAPY (2023)
Neurology consultations in the intensive care units
Tugce Mengi, Taha Aslan, Deniz Varlik Kumus, Erdem Erkoyun, Erdem Yaka
CLINICAL NEUROLOGY AND NEUROSURGERY (2021)
Neurodevelopmental outcomes of preterm infants after randomisation to initial resuscitation with lower (FiO2 ≤0.3) or higher (FiO2 ≥0.6) initial oxygen levels. An individual patient meta-analysis
Ju Lee Oei, Vishal Kapadia, Yacov Rabi, Ola Didrik Saugstad, Denise Rook, Marijn J. Vermeulen, Nuria Boronat, Valerie Thamrin, William Tarnow-Mordi, John Smyth, Ian M. Wright, Kei Lui, Johannes B. van Goudoever, Val Gebski, Maximo Vento
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2022)
VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer
Fiona Chionh, Val Gebski, Sheren J. Al-Obaidi, Jennifer K. Mooi, Maressa A. Bruhn, Chee K. Lee, Anderly C. Chueh, David S. Williams, Andrew J. Weickhardt, Kate Wilson, Andrew M. Scott, John Simes, Jennifer E. Hardingham, Timothy J. Price, John M. Mariadason, Niall C. Tebbutt
SCIENTIFIC REPORTS (2022)
The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancer
K. E. Francis, S. Kim, M. Friedlander, V Gebski, I Ray-Coquard, A. Clamp, R. T. Penson, A. Oza, T. Perri, T. Huzarski, C. Martin-Lorente, S. C. Cecere, N. Colombo, B. Ataseven, K. Fujiwara, G. Sonke, I Vergote, E. Pujade-Lauraine, J-W Kim, C. K. Lee
ANNALS OF ONCOLOGY (2022)
Randomized trial of neoadjuvant chemotherapy with or without concurrent aromatase inhibitor therapy to downstage ER plus ve breast cancer: Breast Cancer Trials Group ANZ 1401 ELIMINATE trial
N. Murray, P. Francis, N. Zdenkowski, N. Wilcken, F. Boyle, V. Gebski, S. M. Tiley, L. Gilham, S-J. Dawson, S. Loi, A. D. Redfern, J. Lombard, A. Spillane, C. Shadbolt, H. Badger
ANNALS OF ONCOLOGY (2022)
A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol
Sina Vatandoust, David Wattchow, Luigi Sposato, Michael Z. Michael, John Leung, Kirsten Gormly, Gang Chen, Erin L. Symonds, Jeanne Tie, Lito Electra Papanicolas, Susan Woods, Val Gebski, Kelly Mead, Aleksandra Kuruni, Christos S. Karapetis
BMC CANCER (2022)
Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma
R. Mercieca-Bebber, E. H. Barnes, K. Wilson, Z. Samoon, E. Walpole, T. Mai, S. Ackland, M. Burge, G. Dickie, D. Watson, J. Leung, T. Wang, R. Bohmer, D. Cameron, J. Simes, V Gebski, M. Smithers, J. Thomas, J. Zalcberg, A. P. Barbour
BMC CANCER (2022)
Toward Incorporating Health-Related Quality of Life as Coprimary End Points in Clinical Trials: Time to Achieve Clinical Important Differences and QoL Profiles
Val Gebski, Andreas Obermair, Monika Janda
JOURNAL OF CLINICAL ONCOLOGY (2022)
Adverse events in the placebo arm of maintenance therapy trials in advanced ovarian cancer: A systematic review and meta-analysis
Sandy Simon, Katherine E. Francis, Janene E. Dalrymple, Val Gebski, Sarah J. Lord, Michael Friedlander, Chee Khoon Lee
EUROPEAN JOURNAL OF CANCER (2022)
Immune checkpoint inhibitors in kidney transplant recipients: a multicentre, single-arm, phase 1 study
Robert P. Carroll, Michael Boyer, Val Gebski, Bronwyn Hockley, Julie K. Johnston, Svjetlana Kireta, Hsiang Tan, Anne Taylor, Kate Wyburn, John RZalcberg
LANCET ONCOLOGY (2022)
Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial
Magnus Nilsson, Halla Olafsdottir, Gabriella Alexandersson von Doebeln, Fernanda Villegas, Giovanna Gagliardi, Mats Hellstroem, Qiao-Li Wang, Hemming Johansson, Val Gebski, Jakob Hedberg, Fredrik Klevebro, Sheraz Markar, Elizabeth Smyth, Pernilla Lagergren, Ghazwan Al-Haidari, Lars Cato Rekstad, Eirik Kjus Aahlin, Bengt Wallner, David Edholm, Jan Johansson, Eva Szabo, John V. Reynolds, C. S. Pramesh, Naveen Mummudi, Amit Joshi, Lorenzo Ferri, Rebecca K. S. Wong, Chris O'Callaghan, Jelena Lukovic, Kelvin K. W. Chan, Trevor Leong, Andrew Barbour, Mark Smithers, Yin Li, Xiaozheng Kang, Feng-Ming Kong, Yin-Kai Chao, Tom Crosby, Christiane Bruns, Hanneke van Laarhoven, Mark van Berge Henegouwen, Richard van Hillegersberg, Riccardo Rosati, Guillaume Piessen, Giovanni de Manzoni, Florian Lordick
FRONTIERS IN ONCOLOGY (2022)
Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer
Katrin M. Sjoquist, Andrew Martin, Nick Pavlakis, David Goldstein, Eric Tsobanis, Daniel Moses, Richard Maher, Wendy Hague, Val Gebski, Martin R. Stockler, R. John Simes
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)
Groin Surveillance by Serial Ultrasonography Rather Than Sentinel Node Biopsy or Inguinofemoral Lymphadenectomy for Patients with Vulvar Cancer: A Pilot Study
Neville F. Hacker, Ellen L. Barlow, Glenn McNally, Stephen Morrell, Val Gebski, Andreas Obermair
CANCERS (2023)
A nomogram to predict progression-free survival benefit with maintenance olaparib and bevacizumab following response to first line chemotherapy in advanced ovarian cancer
Chee Lee, Val Gebski, Katherine Francis, Julien Grenier, Julia Welz, Anna Maria Mosconi, Maria Jesus Rubio-Perez, Christoph Grimm, Takashi Matsumoto, Ignace Vergote, Nicoletta Colombo, Mansoor Raza Mirza, Philippe Follana, Nikolaus de Gregorio, Claudio Zamagni, Yolanda Garcia-Garcia, Jerome Meunier, Eric Pujade-Lauraine, Michael Friedlander, Isabelle Ray-Coquard
GYNECOLOGIC ONCOLOGY (2022)
Open vs. Minimally Invasive Radical Hysterectomy in Early Cervical Cancer: LACC Trial Final Analysis
Pedro Ramirez, Michael Frumovitz, Rene Pareja, David Isla, Kristy Robledo, Rebecca Asher, Val Gebski, Vanessa Behan, Aldo Lopez, Reitan Ribeiro, Xiaojian Yan, Robert Coleman, Andreas Obermair
GYNECOLOGIC ONCOLOGY (2022)
Staging locally advanced cervical cancer with FIGO 2018 versus FIGO 2008: Impact on overall survival and progression-free survival in the OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274).
Linda R. Mileshkin, Kathleen N. Moore, Elizabeth H. Barnes, Yeh Chen Lee, Val Gebski, Kailash Narayan, Nathan Bradshaw, Katrina Diamante, Anthony W. Fyles, William Small, David K. Gaffney, Pearly Khaw, Susan Brooks, J. Spencer Thompson, Warner King Huh, Matthew Carlson, Katina Robison, Danny Rischin, Martin R. Stockler, Bradley J. Monk
JOURNAL OF CLINICAL ONCOLOGY (2022)